ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Condition : By Disease Heading : Rare Diseases : Hepatitis C


Include trials that are no longer recruiting patients.

33 studies were found.
1.RecruitingIdB 1016 Treatment for Hepatitis C Disease
Condition: Hepatitis C, Chronic
2.RecruitingStudy of Viramidine to Ribavirin in Patients with Chronic Hepatitis C Who are Treatment Naive
Condition: Chronic Hepatitis C
3.RecruitingPeg-Ifn Dose Evaluations for Previously Untreated Subjects with Chronic Hepatitis C Infected with Genotype 1
Condition: Chronic Hepatitis C
4.RecruitingPrevention of Disease Progress in Chronic Hepatitis C Patients with Liver Fibrosis
Conditions: Chronic Hepatitis C; Liver Fibrosis
5.RecruitingPeg-Intron for Prevention of Disease Progress in Chronic Hepatitis C Patients with Cirrhosis
Conditions: Chronic Hepatitis C; Cirrhosis
6.RecruitingLong-Term Therapy with Ribavirin for Chronic Hepatitis C
Condition: Chronic Hepatitis C
7.RecruitingDaily dosing of Interferon Alfacon-1 plus Ribavirin for treatment of Hepatitis C Infected Patients (nonresponders)
Condition: Chronic Hepatitis C
8.RecruitingCIFN and IFN γ-1b with or without Ribavirin for treatment of Chronic Hepatitis C (nonresponders)
Condition: Chronic Hepatitis C
9.RecruitingLong-term Peginterferon alpha-2a Plus Ribavirin to Treat Chronic Hepatitis C in HIV-Infected Patients
Conditions: Hepatitis C; HIV Infections
10.RecruitingLeukapheresis for Research on HCV-Coinfected Patients
Conditions: Hepatitis C; HIV Infections
11.RecruitingLow-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected with HCV Genotype 2 or 3
Condition: Hepatitis C
12.RecruitingPegylated Interferon and Ribavirin to Treat Chronic Hepatitis C with and without Kidney Disease
Condition: Hepatitis C
13.RecruitingPeginterferon alpha-2a and ribavirin to treat hepatitis C in HIV-infected patients
Conditions: Hepatitis C; HIV Infections
14.RecruitingRacial Differences in Hepatitis C Virus (HCV)/Host Interactions
Condition: Hepatitis C
15.RecruitingTreatment of Cholestatic Pruritus With Sertraline
Conditions: Pruritus; Liver Cirrhosis, Biliary; Hepatitis C
16.RecruitingRituximab to Treat Hepatitis C-Associated Cryoglobulinemic Vasculitis
Conditions: Hepatitis C; Vasculitis
17.RecruitingPeginterferon alpha-2b And Ribavirin to Treat Hepatitis C in HIV-Infected Patients
Conditions: Hepatitis C; HIV Infections
18.RecruitingImmune Response to Hepatitis C Virus
Condition: Hepatitis C
19.RecruitingFrequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in Japan
Conditions: Hepatitis B; Hepatitis C; HIV Infection
20.RecruitingEpidemiology, Infectivity and Natural History of Hepatitis C Virus Infection
Condition: Hepatitis C
21.RecruitingGenetics of Hepatitis C Virus Infection
Conditions: Hepatitis C; Liver Disease
22.RecruitingA Caspase Inhibitor in Chronic Hepatitis C (HCV) Patients
Condition: Hepatitis C, Chronic
23.RecruitingPegasys in Combination with Copegus in Previously Untreated Patients with Chronic Hepatitis C Genotype 1
Condition: Chronic Hepatitis C
24.RecruitingPegasys in Combination with Copegus in Previously Untreated Patients with Chronic Hepatitis C virus Genotype 2 or 3
Condition: Chronic Hepatitis C
25.RecruitingPEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to alpha-Interferon Plus Ribavirin
Conditions: Chronic Hepatitis C; Liver Fibrosis; Cirrhosis
26.RecruitingMerimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C
Conditions: Hepatitis C; Hepatitis
27.Not yet recruitingA Safety and Efficacy Study of Prophylactically Administered Pegylated Interferon alfa-2a (Pegasys) plus Ribavirin vs. No Prophylaxis Following Liver Transplantation for Hepatitis C
Condition: Hepatitis C
28.RecruitingEvaluation of the viral kinetics and pharmacokinetics of Pegasys plus Copegus and PEG-Intron plus Rebetol in patients with Chronic Hepatitis C and previously untreated with an interferon.
Condition: Hepatitis C
29.RecruitingSafety, feasibility and tolerability of Pegasys plus Copegus in previous intravenous drug users (IVDUs) who are infected with Chronic Hepatitis C and are currently enrolled in a methadone maintenance treatment program
Condition: Hepatitis C
30.RecruitingEfficacy and safety of Pegasys plus Copegus in patients with chronic Hepatitis C who are unable to tolerate or who do not respond to 12 weeks of therapy with PEG-Intron plus Rebetol/Ribavirin.
Condition: Hepatitis C
31.RecruitingPegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)
Conditions: HIV Infections; Hepatitis C; Liver Disease
32.RecruitingEffects of Ribavirin on Zidovudine or Stavudine
Conditions: HIV Infections; Hepatitis C
33.RecruitingHepatitis C: Grading and Staging by MR
Condition: Hepatitis

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act